Satsuma Pharmaceuticals, Inc.
STSA
$0.00
Change (1 day)
$8.08
Year High
$0.59
Year Low
Categories
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can be self-administered with proprietary pre-filled, single-use, and nasal delivery device. Satsuma Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
Dividend history for Satsuma Pharmaceuticals, Inc. (STSA)
Satsuma Pharmaceuticals, Inc. made a total of 7 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $1.50
Dividend payments for Satsuma Pharmaceuticals, Inc. (STSA) from 2012 to 2014
Annual dividend payments
| Date | Dividend | Adj Dividend |
|---|---|---|
| March 28, 14 | $0.20 | $0.20 |
| February 11, 14 | $0.20 | $0.20 |
| November 01, 13 | $0.20 | $0.20 |
| August 02, 13 | $0.20 | $0.20 |
| June 26, 13 | $0.35 | $0.35 |
| May 02, 13 | $0.20 | $0.20 |
| December 19, 12 | $0.15 | $0.15 |